YD Bio Limited Warrants (YDESW) Earnings History
Net Loss2 years of earnings data (2023–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
YD Bio Limited Warrants (YDESW) Earnings Overview
As of July 8, 2026, YD Bio Limited Warrants (YDESW) reported trailing twelve-month net income of -$1M. The company earned $0.00 per diluted share over the past four quarters, with a net profit margin of -276.6%.
Looking at the long-term picture, YDESW's historical earnings data spans multiple years. The company achieved its highest annual net income of $13,560 in fiscal 2023.
YD Bio Limited Warrants is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including BNTX (-$1.26B net income, -39.6% margin), NVAX (-$88M net income, 39.2% margin), OCGN (-$72M net income, -1537.4% margin), YDESW has room to improve margins relative to the peer group. Compare YDESW vs BNTX →
YDESW Earnings vs Peers
Earnings metrics vs comparable public companies
YDESW Historical Earnings Data (2023–2024)
2 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$1M | -10509.7% | -$1M | $0.00 | -276.6% | -286.5% |
| 2023 | $13,560 | - | $-9,847 | $0.00 | 3.9% | -2.8% |
Download Data
Export YDESW earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
3+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
YDESW — Frequently Asked Questions
Quick answers to the most common questions about buying YDESW stock.
What is YDESW earnings per share (EPS)?
YDESW trailing twelve-month (TTM) diluted EPS is $0.00, reflecting N/A year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2023 to 2024 is available in the table on this page.
What is YD Bio Limited Warrants's net income?
YD Bio Limited Warrants (YDESW) trailing twelve-month net income is $-1M as of 2024. Earnings declined N/A year-over-year.
Is YDESW profitable?
YDESW is not currently profitable on a TTM basis, reporting a net loss of $-1M. Net margin is -276.6%. Investors should monitor for a return to profitability.
What is YDESW's earnings growth rate?
YDESW compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2023 to 2024.
What are YDESW's profit margins?
YD Bio Limited Warrants net profit margin is -276.6%, operating margin is -286.5%, and gross margin is +30.4%. Below-average margins reflect competitive or cost pressures. Return on Equity is -42.7%.
Is YDESW growing earnings?
YDESW TTM EPS: $0.00. Net income: $-1M. YoY earnings change: N/A.
What was YDESW's best earnings year?
YD Bio Limited Warrants's highest annual net income on record is $13560.00, achieved in fiscal year 2023. Earnings history on this page spans 2023 to 2024 and includes all annual and quarterly figures.